News from ABBVIE

Jul 18, 2014, 06:17 ET
Jul 18, 2014, 06:14 ET
Jul 18, 2014, 06:12 ET
Jul 18, 2014, 06:10 ET
Jul 16, 2014, 10:00 ET

AbbVie Announces Inaugural Week of Possibilities Volunteer Program to Support Six Schools in North Chicago, Ill., and Worcester, Mass.

AbbVie today announced its first Week of Possibilities, an employee volunteer program to support educational improvement projects in local...

Jul 08, 2014, 07:50 ET
Jun 26, 2014, 08:00 ET

AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) in Patients with Advanced Breast Cancer

AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational...

Jun 25, 2014, 08:45 ET
Jun 25, 2014, 07:05 ET
Jun 25, 2014, 07:00 ET
Jun 23, 2014, 07:45 ET
Jun 19, 2014, 23:48 ET
Jun 19, 2014, 11:28 ET

AbbVie Declares Quarterly Dividend

 The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.42 per share.  The cash dividend is payable...

Jun 17, 2014, 02:00 ET

European Medicines Agency Validates Marketing Authorization Applications for AbbVie's Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C

AbbVie (NYSE: ABBV) announced today that the Marketing Authorization Applications (MAAs) for its investigational, all-oral, interferon-free regimen...

Jun 13, 2014, 15:34 ET

U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C

 AbbVie (NYSE: ABBV) announced today that the New Drug Application (NDA) for its investigational, all-oral, interferon-free regimen for the...

Jun 11, 2014, 02:00 ET

AbbVie Presents Results from Large Global Study of Patient Attitudes and Adherence Across Six Chronic Inflammatory Diseases

 AbbVie (NYSE:ABBV) today announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated...

Jun 10, 2014, 08:00 ET

AbbVie to Present at Goldman Sachs 35th Annual Global Healthcare Conference

 AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 35th Annual Global Healthcare Conference on Wednesday, June 11, 2014. Bill Chase,...

Jun 03, 2014, 08:30 ET

AbbVie to Present at Jefferies 2014 Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Jefferies 2014 Global Healthcare Conference on Wednesday, June 4, 2014. Scott Brun, M.D., vice...

May 31, 2014, 08:00 ET

AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting

AbbVie (NYSE: ABBV) released interim results from a Phase Ib clinical trial of ABT-199/GDC-0199, an investigational B-cell lymphoma 2 (BCL-2)...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review